There were 1,841 press releases posted in the last 24 hours and 442,443 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
resTORbio Announces Delay of its Ongoing Phase 1b/2a trial of RTB101 in Patients with Parkinson’s Disease Due to COVID-19 Level 4 Alert in New Zealand

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image